Source: Eur Respir J, 55 (6) 2000858; 10.1183/13993003.00858-2020
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Maroun Khoury, Jimena Cuenca, Fernanda F. Cruz, Fernando E. Figueroa, Patricia R.M. Rocco, Daniel J. Weiss. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19. Eur Respir J, 55 (6) 2000858; 10.1183/13993003.00858-2020

Member's Comments

No comment yet.

Related content which might interest you: From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections Source: International Congress 2017 – Scientific year in review Year: 2017 Are antimicrobials still the future of respiratory infection therapy? Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019 Update on management of new emerging acute respiratory viral infectious diseases Source: International Congress 2018 – Chinese Programme 2018: Part I Year: 2018 The role of virus infections in asthma: immune responses and future possibilities Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection Year: 2007 New treatments for RSV and other viruses, including update on vaccines Source: ERS Courses: Paediatric respiratory infections Year: 2019 The efficacy of antiviral therapy of acute respiratory infections in paediatric practice Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017 Emerging respiratory virus infections threaten pulmonary health Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease Year: 2021 The immunology of virus infection in asthma Source: Eur Respir J 2001; 18: 1013-1025 Year: 2001 Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies Source: International Congress 2019 – Scientific Year in review Year: 2019 Economic aspects of enhanced testing strategies for respiratory diseases Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021 Simultaneous use of probiotics and vaccines for prevention of pneumonia and respiratory infections in servicemen Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006 Prevention and treatment of viral infections: CMV and other community respiratory viruses Source: ERS Course 2016 Year: 2016 Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Applying new respiratory function technologies to the elderly and the potential of future lung regeneration Source: Virtual Congress 2020 – Lung health and respiratory function at all ages Year: 2020